Mihoko Usami

871 citations
21 papers · 736 indexed · h-index 15
Topics
Alzheimer's disease research and treatments (15 papers)Prion Diseases and Protein Misfolding (5 papers)Cholinesterase and Neurodegenerative Diseases (5 papers)

In The Last Decade

Mihoko Usami

21 papers receiving 717 citations

Peers

Mihoko Usami
Comparison fields: 5 of 66
  • Physiology 490
  • Molecular Biology 424
  • Cellular and Molecular Neuroscience 115
  • Cell Biology 105
  • Pharmacology 100
Replace Jeffrey S. Farrow with:
Jeffrey S. Farrow United States
Christopher Böhm Canada
M. Vandermeeren Belgium
Carole Ho United States
H. Backhovens Belgium
Mirsada Čaušević United Kingdom
Inge Grundke-Iqbal United States
J. Miller United States
Georges Lévesque Canada
R Bhasin United States
Mihoko Usami relative to Jeffrey S. Farrow United States Jeffrey S. Farrow's profile →
Citations per field
00.5×1.5×
Jeffrey S. Farrow · 1×
Citations per year

Countries citing papers authored by Mihoko Usami

Since Specialization
Citations

This map shows the geographic impact of Mihoko Usami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihoko Usami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihoko Usami more than expected).

Fields of papers citing papers by Mihoko Usami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihoko Usami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihoko Usami. The network helps show where Mihoko Usami may publish in the future.

Co-authorship network of co-authors of Mihoko Usami

This figure shows the co-authorship network connecting the top 25 collaborators of Mihoko Usami. A scholar is included among the top collaborators of Mihoko Usami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihoko Usami. Mihoko Usami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 30
3 1
4 28
5 5
6 20
7 31
8 41
9 14
10 39
11 104
12 6
13 10
14 133
15 19
16 80
17 101
18 3
19 12
20 14

About Mihoko Usami

Mihoko Usami is a scholar working on Physiology, Cell Biology and Pharmacology, having authored 21 papers that have together received 736 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (15 papers), Prion Diseases and Protein Misfolding (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). The work is most often cited by research in Physiology (490 citations), Neurology (61 citations) and Cell Biology (105 citations). Mihoko Usami has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Kei Maruyama, Kazuaki Yoshikawa, Takako Aizawa, Fuyuki Kametani, Kiyoshi Terakado, Wakako Yamao‐Harigaya, Naruhiko Sahara, Hiroshi Mori, Akira Takahashi and Kenji Hosoda. Their work appears in journals such as Nature, The Journal of Physiology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026